New Therapies for Pemphigus Vulgaris Beyond Rituximab
Recent advances in treating Pemphigus Vulgaris have introduced therapies that go beyond the use of Rituximab. These new treatment options aim to improve patient outcomes by targeting different pathways involved in the disease, offering alternatives for those who do not respond well to Rituximab or experience side effects. This marks a significant development in managing this autoimmune condition.
EMJ·



